| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NURE.12093 |
| P698 | PubMed publication ID | 24665956 |
| P50 | author | Simona Serini | Q59671504 |
| Gabriella Calviello | Q59671507 | ||
| P2093 | author name string | Achille Cittadini | |
| Elena Fasano | |||
| Leonardo Celleno | |||
| P2860 | cites work | Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC | Q24336321 |
| Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention | Q26830150 | ||
| Melanoma in Western Australia 1975-76 to 1980-81: trends in demographic and pathological characteristics. | Q50577967 | ||
| Eicosapentaenoic acid reduces the invasive and metastatic activities of malignant tumor cells. | Q52246668 | ||
| The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. | Q52864305 | ||
| Rethinking lipid mediators. | Q52937044 | ||
| Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR | Q58453187 | ||
| Fat-1 mice convert n-6 to n-3 fatty acids | Q59062098 | ||
| Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths | Q28241157 | ||
| Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model | Q28306770 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Chemoprevention of melanoma: an unexplored strategy | Q31123127 | ||
| Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale | Q33448682 | ||
| Human requirement for N-3 polyunsaturated fatty acids | Q33910189 | ||
| Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults | Q34454415 | ||
| Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins | Q34522097 | ||
| Novel formulations of taxanes: a review. Old wine in a new bottle? | Q34563540 | ||
| Progress in COX-2 inhibitors: a journey so far. | Q34616908 | ||
| Alternative sources of omega-3 fats: can we find a sustainable substitute for fish? | Q34650675 | ||
| Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century | Q34793063 | ||
| Phase 3 study of docosahexaenoic acid–paclitaxel versus dacarbazine in patients with metastatic malignant melanoma | Q35003419 | ||
| Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids | Q35033761 | ||
| PTEN signaling pathways in melanoma | Q35146572 | ||
| Resolvins and protectins in inflammation resolution. | Q35332873 | ||
| Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model | Q35345202 | ||
| Omega-3 fatty acids and inflammatory processes | Q35670928 | ||
| Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma | Q35680356 | ||
| Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells | Q35980185 | ||
| The effect of omega-6 and omega-3 fatty acids on 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ | Q35994113 | ||
| Omega-3 fatty acids status in human subjects estimated using a food frequency questionnaire and plasma phospholipids levels | Q36143491 | ||
| Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. | Q36231619 | ||
| Bioactive food components, inflammatory targets, and cancer prevention | Q36254183 | ||
| Polyunsaturated Fatty acids of marine macroalgae: potential for nutritional and pharmaceutical applications. | Q36329848 | ||
| Modulation of lipid rafts by Omega-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support | Q36715129 | ||
| Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis | Q36782159 | ||
| Cyclooxygenases, prostanoids, and tumor progression | Q36925833 | ||
| n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. | Q37066065 | ||
| Pathways connecting inflammation and cancer | Q37104251 | ||
| Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma | Q37290822 | ||
| Melanoma and innate immunity--aActive inflammation or just erroneous attraction? Melanoma as the source of leukocyte-attracting chemokines. | Q37336165 | ||
| Dietary polyunsaturated fatty acids as inducers of apoptosis: implications for cancer. | Q37364559 | ||
| Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. | Q37427057 | ||
| Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. | Q37438352 | ||
| Inflammation and melanoma metastasis | Q37445162 | ||
| Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies. | Q37448363 | ||
| Chronic inflammation, the tumor microenvironment and carcinogenesis | Q37528888 | ||
| Dietary n-3 PUFA vascular targeting and the prevention of tumor growth and age-related macular degeneration. | Q37630661 | ||
| Naturally occurring, tumor-specific, therapeutic proteins | Q37869260 | ||
| Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects. | Q37929141 | ||
| Thymoquinone: potential cure for inflammatory disorders and cancer | Q37946658 | ||
| Cancers with increasing incidence trends in the United States: 1999 through 2008. | Q37979107 | ||
| Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. | Q37998751 | ||
| Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs | Q38006268 | ||
| Non-steroidal anti-inflammatory drugs and melanoma | Q38013295 | ||
| Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring | Q38091649 | ||
| DHA induces apoptosis and differentiation in human melanoma cells in vitro: involvement of HuR-mediated COX-2 mRNA stabilization and β-catenin nuclear translocation | Q39449462 | ||
| Effects of thymoquinone-fatty acid conjugates on cancer cells | Q39868050 | ||
| The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer | Q39994007 | ||
| Involvement of PPAR-gamma and p53 in DHA-induced apoptosis in Reh cells. | Q40135452 | ||
| Synthesis and preliminary antitumor activity evaluation of a DHA and doxorubicin conjugate | Q40300110 | ||
| Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma | Q40445795 | ||
| Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells. | Q40513050 | ||
| Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. | Q40549285 | ||
| Cancers of skin, bone, connective tissues, brain, eye, thyroid and other specified and unspecified sites in Inuit | Q40958377 | ||
| Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines | Q41087687 | ||
| The role of docosahexaenoic acid in mediating mitochondrial membrane lipid oxidation and apoptosis in colonocytes | Q42410882 | ||
| Polyunsaturated fatty acids partially reproduce the role of melanocytes in the epidermal melanin unit | Q42474944 | ||
| Phase 2 open-label study of weekly docosahexaenoic acid–paclitaxel in patients with metastatic uveal melanoma | Q42873369 | ||
| Estimated macronutrient and fatty acid intakes from an East African Paleolithic diet | Q42879612 | ||
| Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis | Q43116331 | ||
| Are some melanomas caused by artificial light? | Q43116641 | ||
| Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses | Q43532695 | ||
| Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate | Q43844053 | ||
| Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells | Q44239025 | ||
| The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines | Q44381231 | ||
| gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. | Q44381244 | ||
| Effects of 10alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations in rat bone marrow cells | Q44910549 | ||
| Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignancies | Q44937628 | ||
| Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells | Q45009097 | ||
| n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway | Q45052756 | ||
| Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil | Q45057792 | ||
| Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved | Q45400767 | ||
| Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients. | Q45972029 | ||
| Lipid composition and contaminants in farmed and wild salmon | Q46832202 | ||
| The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. | Q47963945 | ||
| Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. | Q50336851 | ||
| The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. | Q50547663 | ||
| P433 | issue | 4 | |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 255-266 | |
| P577 | publication date | 2014-03-25 | |
| P1433 | published in | Nutrition Reviews | Q15765213 |
| P1476 | title | Potential of long-chain n-3 polyunsaturated fatty acids in melanoma prevention | |
| P478 | volume | 72 |
| Q37640301 | Gas chromatography-mass spectrometry analysis of effects of dietary fish oil on total fatty acid composition in mouse skin |
| Q49858809 | Monooxygenase system in Guerin’s carcinoma of rats under conditions of ω-3 polyunsaturated fatty acids administration. |
| Q64097121 | Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases |
| Q35976923 | Nucleotide excision repair deficiency increases levels of acrolein-derived cyclic DNA adduct and sensitizes cells to apoptosis induced by docosahexaenoic acid and acrolein |
| Q26798057 | Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence |
| Q52329039 | Omega-3 fatty acids, membrane remodeling and cancer prevention. |
| Q49923462 | The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines |
Search more.